A clinical trial is testing whether a smartphone app called SPARC, which prompts users to perform meditative breathing exercises and contains disease-relevant education modules, can help ease fatigue and improve life quality for people with sarcoidosis. Mobile app SPARC is short for Sarcoidosis Patient Resource and Companion. The study (NCT05230693), sponsored by the Medical University of South Carolina, is underway at the university.
SPARC Clinical Trial
Categories
Recent Posts
- FSR Warns of Increased Risk of Sarcoidosis from Fire and Smoke Exposure
- Important Clinical Trial Results Announcement for Sarcoidosis Patients
- FSR Doubles Investment in Cardiac Sarcoidosis Research with $200,000 in Grants to Advance Diagnostic and Treatment Breakthroughs
- FSR receives confirmation from the Department of Labor ensuring patient access to FMLA for participation in clinical trials
- Nearly 350 Patients Participate in the Foundation for Sarcoidosis Research Externally Led Patient-Focused Drug Development Meeting with the FDA